SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-23-042716
Filing Date
2023-12-27
Accepted
2023-12-27 17:26:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A a20231227defa-14a.htm DEFA14A 69388
2 image_0.jpg GRAPHIC 29102
3 image_01.jpg GRAPHIC 21873
  Complete submission text file 0001628280-23-042716.txt   138579
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-21088 | Film No.: 231518878
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)